Skip to main content

Table 2 Fistula closure and residual incontinence outcomes at discharge and 3 month follow-up, by site

From: Clinical procedures and practices used in the perioperative treatment of female genital fistula during a prospective cohort study

 

Site N (%)

 

Total (n = 1354)

BG 1 (n = 85)

BG 2 (n = 50)

BG 3 (n = 5)

GU (n = 251)

NI 1 (n = 74)

NI 2 (n = 97)

NG 1 (n = 59)

NG 2 (n = 210)

NG 3 (n = 153)

UG 1 (n = 165)

UG 2 (n = 205)

Urinary fistula closure at end of repair surgery (n = 1299)

1245 (95.8)

73 (88.0)

45 (93.8)

5 (100.0)

231 (93.9)

63 (95.5)

89 (100)

50 (94.3)

195 (95.1)

141 (94.6)

155 (99.4)

198 (99.5)

Urinary fistula closure at discharge (n = 1307)

1104 (84.5)

62 (75.6)

34 (70.8)

5 (100.0)

204 (82.9)

40 (59.7)

72 (86.8)

39 (72.2)

189 (90.9)

115 (76.5)

141 (88.1)

203 (100.0)

Urinary fistula closure at 3 month follow-up (n = 1274)

1039 (81.6)

52 (73.2)

34 (70.8)

3 (60.0)

185 (75.2)

40 (59.7)

45 (66.2)

37 (69.8)

190 (91.4)

117 (80.1)

138 (86.8)

198 (97.5)

Residual incontinence at discharge among women with urinary fistula (n = 1084)

219 (20.2)

19 (32.8)

9 (27.3)

2 (66.7)

28 (13.7)

3 (7.9)

17 (24.3)

12 (31.6)

21 (11.2)

35 (31.0)

26 (18.6)

47 23.62

Residual incontinence at 3 months follow-up among women with urinary fistula (n = 1015)

192 (18.9)

9 (19.2)

16 (47.1)

3 (100.0)

23 (12.5)

4 (10.5)

18 (40.9)

8 (21.6)

18 (9.8)

34 (29.1)

15 (10.9)

44 (23.3)

RVF Closure at discharge (n = 47)

44 (93.6)

1 (100.0)

2 (100.0)

N/A

9 (90.0)

2 (100.0)

4 (100.0)

3 (100.0)

5 (71.4)

6 (100.0)

5 (100.0)

7 (100.0)

RVF Closure at 3 month follow-up (n = 43)

36 (83.7)

1 (100.0)

1 (50.0)

N/A

8 (80.0)

3 (100.0)

2 (100.0)

3 (100.0)

3 (75.0)

3 (50.0)

5 (100.0)

7 (100.0)

  1. BG = Bangladesh, GU = Guinea, NI = Niger, NG = Nigeria, UG = Uganda.
  2. N/A = not applicable.